Показано 0 из 0
Дата |
---|
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
3.88
|
3.88
|
3.96
|
3.96
|
|
|
|
|
|
|
3.56
|
3.56
|
3.56
|
3.56
|
|
|
|
|
|
|
3.50
|
3.50
|
3.58
|
3.58
|
|
|
|
|
|
|
3.58
|
3.58
|
3.58
|
3.58
|
|
|
|
|
|
|
3.42
|
3.42
|
3.42
|
3.42
|
|
|
|
|
|
|
3.24
|
3.12
|
3.24
|
3.16
|
|
|
|
|
|
|
3.14
|
3.14
|
3.32
|
3.26
|
|
|
|
|
|
|
3.14
|
3.14
|
3.14
|
3.14
|
|
|
|
|
|
|
3.18
|
3.12
|
3.18
|
3.16
|
|
|
|
|
|
|
3.42
|
3.18
|
3.42
|
3.18
|
|
|
|
|
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis platform, XpressCF.